{"title":"人肉瘤细胞对宿主细胞溶解性淋巴样细胞的自我防御。","authors":"Joseph G Sinkovics, Joseph C Horvath","doi":"10.1556/1886.2021.11111","DOIUrl":null,"url":null,"abstract":"<p><p>Metastatic human sarcomas temporarily respond to radio-chemotherapy relapse and remain highly resistant to further combination chemotherapy as to a curative effect, including checkpoint control.</p>","PeriodicalId":11929,"journal":{"name":"European Journal of Microbiology & Immunology","volume":"11 2","pages":"44-49"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/c2/eujmi-11-044.PMC8287976.pdf","citationCount":"0","resultStr":"{\"title\":\"Self-defense of human sarcoma cells against cytolytic lymphoid cells of their host.\",\"authors\":\"Joseph G Sinkovics, Joseph C Horvath\",\"doi\":\"10.1556/1886.2021.11111\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Metastatic human sarcomas temporarily respond to radio-chemotherapy relapse and remain highly resistant to further combination chemotherapy as to a curative effect, including checkpoint control.</p>\",\"PeriodicalId\":11929,\"journal\":{\"name\":\"European Journal of Microbiology & Immunology\",\"volume\":\"11 2\",\"pages\":\"44-49\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/c2/eujmi-11-044.PMC8287976.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Microbiology & Immunology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1556/1886.2021.11111\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Microbiology & Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1556/1886.2021.11111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Self-defense of human sarcoma cells against cytolytic lymphoid cells of their host.
Metastatic human sarcomas temporarily respond to radio-chemotherapy relapse and remain highly resistant to further combination chemotherapy as to a curative effect, including checkpoint control.